• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Optive Research Teams With Microsoft, HP, and AMD for High Performance Drug Discovery

Posted on: Monday, 8 November 2004, 09:00 CST

Companies to Demonstrate Discovery Informatics Solutions based on Windows Server 2003 on AMD Opteron(TM) Processor-Powered HP Clusters at Supercomputing 2004 Conference

Optive Research, Inc., a life sciences software company providing innovative solutions for computer-assisted molecular discovery, today announced that it has expanded its work with Microsoft and HP (NYSE:HPQ), and has initiated a relationship with AMD (NYSE:AMD) to provide additional High Performance Computing (HPC) platform options for its customers.

The companies are scheduled to demonstrate Optive's Discovery Informatics products on a beta version of the Microsoft Windows Server 2003, Enterprise x64 Edition operating system and HP ProLiant DL145-based clusters powered by AMD Opteron(TM) processors at Supercomputing 2004. The demo will take place in Microsoft's booth #1815 at Supercomputing 2004, in Pittsburgh, Nov. 8-11.

"The performance of our Discovery Informatics products, including the popular Concord(TM) program for 3D chemical structure generation, on the Windows Server 2003 operating system with AMD Opteron processor-powered HP clusters has been impressive," said Davin Potts, Ph.D., senior scientist with Optive Research. "Based on internal benchmarks, the OS is achieving at least platform parity with several flavors of Linux, and in some cases we are seeing as high as 50 percent faster overall performance when compared to Red Hat Enterprise Linux 3.0."

Microsoft is scheduled to deliver the HPC version of Windows Server 2003, to be called Windows Server 2003, Compute Cluster Edition, in the second half of 2005. Optive is planning to add Windows Server 2003, Compute Cluster Edition, to its list of supported Discovery Informatics platforms, which currently includes the IRIX(R) and Linux operating systems.

"High performance computing is one of the fastest growing server workloads worldwide, with applications in many industry verticals to solve complex business, technical, and scientific problems," said Kyril Faenov, director of HPC at Microsoft. "Our collaboration with Optive Research is helping Microsoft better understand the unique HPC requirements facing discovery scientists at many of the world's leading pharmaceutical companies. This interaction will help ensure that Windows Server 2003, Compute Cluster Edition, will be designed to meet the needs of the Life Science community."

For more information about Windows Server 2003 and High Performance Computing at Microsoft, visit: http://www.microsoft.com/hpc.

For more information about HP ProLiant DL145 clusters, featuring the AMD Opteron processor, visit: http://h18004.www1.hp.com/products/servers/proliantdl145.

About Optive Research, Inc.

Optive Research develops, markets and supports life science software solutions that help companies engaged in molecular discovery research bring beneficial chemical compounds to market faster, while reducing overall cost. Optive's novel software is designed for both computational chemists and experimental, "wet-lab" scientists, enabling them to reduce discovery cycle times and synthesize higher-quality lead compounds, thereby achieving more predictable discovery and development processes. Software developed by Optive Research is currently in use at almost every major pharmaceutical company and at hundreds of other research sites worldwide. More information about Optive Research is available at www.optive.com.

Product and company names herein may be trademarks of their registered owners.

Copyright (C) 2004 Optive Research, Inc. All Rights Reserved. Concord is a trademark of the University of Texas at Austin. Other product and service names mentioned herein are the trademarks of their respective owners.

Source: Business Wire

More News in this Category